My Eyes, My Light: Amar Chokh, Amar Alo
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This trial is studying people living in Char Fasson, Bangladesh, to see who might have undiagnosed eye problems. It's a local screening program to catch eye issues early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 35 years of age or older.
- You must live in the Char Fasson sub-district (Bhola District).
- You should not have a known eye disease diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a village-based approach to bring eye care closer to older community members. If you live in the right area and are willing to participate, it may help improve access to eye screening and services.
This study tests a new way to help people with eye problems get from a community clinic to a hospital for surgery or specialist care. It aims to make sure follow-up and treatment are completed.
This trial is testing a new, intelligent way to screen for and diagnose eye diseases using a mobile device. It may help catch eye problems early, especially in people who have trouble getting to a doctor.
This study tests a program that combines diabetes care with eye exams for people in Bangladesh who were recently diagnosed with diabetes. The goal is to see if this approach helps you better manage your health and prevent vision problems.
This study tests a new way to combine diabetes care with eye care for people with diabetes in Bangladesh. If you have diabetes and a diabetes-related eye condition, this might help improve your care.
This study uses detailed eye imaging to look for patterns that may go along with conditions like Alzheimer’s disease, memory problems, multiple sclerosis, or eye/vascular issues. It may help researchers better understand how eye findings relate to health and disease.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.